Developing New Therapies for Lymphoma

Finding new ways to treat resistant lymphoma

MD Anderson
Houston, TX Dr. Michelle Fanale

The National Stem Cell Foundation is in its second year of funding for research being conducted by Dr. Michelle Fanale at MD Anderson, Houston. With a goal of developing new therapies for patients with advanced or relapsed disease, Dr. Fanale was the recipient of a grant to test a multi-drug therapy option for patients with resistant lymphoma. Four patients in the trial with resistant T-cell lymphoma have had remarkable outcomes to date – one participant is currently cancer free and three are responding to treatment. The data was presented at the ASH (American Society of Hematology) Annual Meeting in December 2014 and is the subject of a paper that Dr. Fanale hopes to have published shortly in a peer-­reviewed journal.